Research Topics
Genomes and GenesSpecies | J T O'BrienSummaryAffiliation: University of Newcastle Country: UK Publications
| Collaborators
|
Detail Information
Publications
Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodiesJohn T O'Brien
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK
Br J Psychiatry 194:34-9. 2009..123)I-FP-CIT SPECT (single photon emission computed tomography) can help in the differential diagnosis of probable dementia with Lewy bodies (Lewy body dementia) and Alzheimer's disease...
Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocationStephen G O'Brien
School of Clinical and Laboratory Sciences and the School of Biochemistry and Genetics, University of Newcastle, United Kingdom
Blood 99:3465-7. 2002..This case has implications for the design of future studies using STI571 in leukemias involving ABL-encoded fusion proteins other than BCR-ABL...
Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular diseaseJOHN O'BRIEN
Institute for Ageing and Health, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
J Neurol Sci 203:41-8. 2002..Such differences in untreated outcome need to be considered when interpreting trial results using outcome measures that were largely designed for studies of patients with AD...
Cognitive associations of subcortical white matter lesions in older peopleJohn T O'Brien
Institute for Ageing and Health, Wolfson Research Centre, University of Newcastle upon Tyne, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
Ann N Y Acad Sci 977:436-44. 2002....
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodiesJohn T O'Brien
Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, England
Arch Neurol 61:919-25. 2004..Dementia with Lewy bodies (DLB) is a common form of late-life dementia that can be difficult to differentiate from other disorders, especially Alzheimer disease (AD), during life. At autopsy the striatal dopaminergic transporter is reduced...
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemiaS G O'Brien
Department of Haematology, University of Newcastle Medical School, Royal Victoria Infirmary, New Castle NE1 4LP, UK
Br J Cancer 89:1855-9. 2003..The coadministration of simvastatin with imatinib (400 mg) was well tolerated and no major safety findings were reported in this study...
Behavioral symptoms in vascular cognitive impairment and vascular dementiaJOHN O'BRIEN
Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, UK
Int Psychogeriatr 15:133-8. 2003..There is a particularly strong relationship between cerebrovascular disease and depression...
Dementia associated with psychiatric disordersJOHN O'BRIEN
Wolfson Research Centre, Institute for Ageing and Health, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
Int Psychogeriatr 17:S207-21. 2005..The paper also discusses some of the mechanisms that may contribute to the expression of the cognitive deficits in these disorders and their potential relationship with common causes of dementia...
Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressureMichael J Firbank
Institute for Ageing and Health, Wolfson Research Centre, Newcastle upon Tyne, NE4 6BE, UK
J Neurol 254:713-21. 2007..These changes are independent. Successful hypertension treatment was associated with reduced risk of WMH progression and possibly brain atrophy...
Role of imaging techniques in the diagnosis of dementiaJ T O'Brien
Newcastle University, Institute for Ageing and Health, Wolfson Research Centre, Newcastle upon Tyne, UK
Br J Radiol 80:S71-7. 2007..Newer techniques show great promise to detect specific neuroreceptor changes as well as pathological underpinnings of dementia, such as amyloid and tau pathology...
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementiaJ T O'Brien
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
Neurology 56:1386-8. 2001..The authors found accelerating atrophy with increasing severity of cognitive impairment, further emphasizing the need for early diagnosis and intervention in dementia...
The association between white matter lesions on magnetic resonance imaging and noncognitive symptomsJ O'BRIEN
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, UK
Ann N Y Acad Sci 903:482-9. 2000..Further study of the neurobiological basis of WML is needed. This can best be achieved by serial clinical assessment combined with in vivo and in vitro MRI and neuropathological examination...
Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controlsJ T O'Brien
University of Newcastle upon Tyne, UK
Int Psychogeriatr 13:149-61. 2001..To compare the utility of temporal lobe magnetic resonance imaging (MRI) and single-photon emission tomography (SPET) scanning in discriminating between subjects with Alzheimer's disease (AD) and age-matched controls...
Medial temporal lobe width on CT scanning in Alzheimer's disease: comparison with vascular dementia, depression and dementia with Lewy bodiesJ T O'Brien
Institute for the Health of the Elderly, University of Newcastle upon Tyne, Glasgow, UK
Dement Geriatr Cogn Disord 11:114-8. 2000..We conclude that a single cross-sectional measurement of MTL width on CT does not help differentiate between different types of dementia, though it may provide some supportive evidence when distinguishing depression from dementia...
Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up studyJ O'BRIEN
Department of Psychiatry and Institute for the Health of the Elderly, University of Newcastle upon Tyne, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE
BMJ 317:982-4. 1998..To determine the difference in outcome among elderly people with major depression who do and do not have severe white matter lesions on magnetic resonance imaging...
The application of serial MRI analysis techniques to the study of cerebral atrophy in late-onset dementiaS M Paling
Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
Med Image Anal 8:69-79. 2004..001) compared to controls. In general the analysis technique is shown to be a robust, accurate and transferable tool of potential value for future studies of dementia and related neuro-degenerative disorders...
A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric studyR Barber
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, UK
Dement Geriatr Cogn Disord 12:198-205. 2001....
Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosisE J Burton
Wolfson Research Centre, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK
Brain 132:195-203. 2009..Pathologically, it is more strongly related to tangle rather than plaque or Lewy body pathology in the temporal lobe. It may have utility as a means for stratifying samples in vivo on the basis of putative differences in pathology...
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementiaM P Walker
Medical Research Council Neurochemical Pathology Unit, Institute for the Health of the Elderly, Newcastle, UK
Neurology 54:1616-25. 2000..Case reports and clinical observations suggest that fluctuating cognition (FC) is common in the major dementias, particularly dementia with Lewy bodies (DLB), where it is one of three core clinical diagnostic features...
The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-upC G Ballard
Medical Research Council, Neurochemical Pathology Unit, Newcastle upon Tyne, England
J Clin Psychiatry 62:46-9. 2001..Few data are available regarding the natural course of psychiatric symptoms in dementia with Lewy bodies and Alzheimer's disease. To acquire this information is essential to inform differential diagnosis and treatment decisions...
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotypeJ P Taylor
Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
J Neurol Neurosurg Psychiatry 79:1318-23. 2008..People with PD display attentional deficits; however, it is not clear whether attentional deficits in patients with non-demented PD are associated with (i) PIGD phenotype and/or (ii) subsequent cognitive decline...
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS studyA Teodorczuk
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne NE4 5PL, UK
Psychol Med 40:603-10. 2010..We investigated whether baseline severity of cerebral white-matter changes predict longer-term future depressive outcomes in a community sample of non-disabled older adults...
MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's diseaseR Barber
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, UK
Int J Geriatr Psychiatry 15:911-6. 2000..In particular, PVH appear to be linked to atrophic processes involving ventricular enlargement and DWMH to ischaemic risk factors...
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodiesD J Burn
Institute for Ageing and Health, University of Newcastle, Newcastle upon Tyne, NE4 6BE, UK
J Neurol Neurosurg Psychiatry 77:585-9. 2006....
APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairmentC G Ballard
Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Rd, Newcastle upon Tyne, NE4 6BE, UK
Neurology 63:1399-402. 2004..Dementia is common post stroke, but the potential role of early cognitive impairment and APOE epsilon4 as risk factors is unclear...
White matter changes and late-life depressive symptoms: longitudinal studyA Teodorczuk
Institute for Ageing and Health, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
Br J Psychiatry 191:212-7. 2007..Evidence from cross-sectional studies suggests a link between cerebral age-related white matter changes and depressive symptoms in older people, although the temporal association remains unclear...
Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flowS J Colloby
Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Neurobiol Aging 32:293-301. 2011..I-5IA-85380 binding was compared to corresponding regional cerebral blood flow (rCBF) changes in the same subjects...
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometryE J Burton
Institute for Ageing and Health, University of Newcastle upon Tyne, United Kingdom
Neuroimage 17:618-30. 2002..Comparison of dementia groups showed preservation of the medial temporal lobe, hippocampus, and amygdala in DLB relative to AD. Significant gray matter loss was also observed in the thalamus of AD patients compared to DLB...
Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated casesA J Lloyd
Clinical Research Associate, Wolfson Research Centre, Newcastle General Hospital, Newcastle NE4 6BE, UK
Int J Geriatr Psychiatry 16:281-7. 2001..The association of depression with vascular risk factors is considered, as is the relationship between depression and cognitive deficits. There is a need for further investigation in this area...
Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one yearM J Firbank
Institute for Ageing and Health, University of Newcastle upon Tyne, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, NE4 6BE, UK
J Neurol Neurosurg Psychiatry 76:1448-51. 2005..Brain perfusion deficits have been reported previously in subjects with Parkinson's disease in comparison with healthy controls...
Visual perception in Parkinson disease dementia and dementia with Lewy bodiesU P Mosimann
Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, UK
Neurology 63:2091-6. 2004..To quantify visual discrimination, space-motion, and object-form perception in patients with Parkinson disease dementia (PDD), dementia with Lewy bodies (DLB), and Alzheimer disease (AD)...
A comparison of neurocognitive impairment in younger and older adults with major depressionA J Thomas
Institute for Ageing and Health, Newcastle University, UK
Psychol Med 39:725-33. 2009..We hypothesized that ageing alone would not fully explain the increased neurocognitive impairment in late-life depression but that differences in the illness explain the greater decrements in memory and executive function...
Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortexA J Thomas
Department of Psychiatry, University of Newcastle upon Tyne, UK
Am J Psychiatry 157:1682-4. 2000..The authors investigated this association by determining whether intercellular adhesion molecule-1 (ICAM-1), a marker of ischemia-induced inflammation, is elevated in the dorsolateral prefrontal cortex in depression...
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementiasR Barber
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, England
Arch Neurol 56:961-5. 1999..To examine the relationship between the apolipoprotein E (APOE) epsilon4 genotype, medial temporal lobe atrophy, and white matter hyperintensities on magnetic resonance imaging in late-life dementias...
Medial temporal lobe atrophy on MRI in dementia with Lewy bodiesR Barber
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, UK
Neurology 52:1153-8. 1999....
Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical studyS Davis
Wolfson Research Centre, Institute for Aging and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
J Neurol Neurosurg Psychiatry 73:556-60. 2002....
Regional cerebral blood flow in Parkinson's disease with and without dementiaM J Firbank
Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE, UK
Neuroimage 20:1309-19. 2003..The perfusion deficits in PDD are similar those in DLB, and in a location associated with visual processing, and may be associated with the visuospatial perception deficits which are present in persons with DLB and PDD...
The pattern and course of cognitive impairment in late-life depressionS Kohler
Wolfson Research Centre, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
Psychol Med 40:591-602. 2010..To investigate this, we followed the pattern of cognitive impairments over time and examined the effects of current mood, remission status, age of depression onset and antidepressant (AD) treatment on these deficits...
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodiesS A Molloy
Institute of Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, UK
J Neurol Neurosurg Psychiatry 77:1323-8. 2006..Therefore, the effect of L-dopa on the cognitive profile of dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) is unclear...
Cerebral blood flow by arterial spin labeling in poststroke dementiaM J Firbank
Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne, UK
Neurology 76:1478-84. 2011..To investigate the relationship between cerebral blood flow and dementia in older stroke survivors and subjects with Alzheimer disease (AD)...
MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementiaR Barber
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, UK
Neurology 54:1304-9. 2000..To compare global and regional atrophy on MRI in subjects with dementia with Lewy bodies (DLB), AD, vascular dementia (VaD), and normal aging. In addition, the relationship between APOE-epsilon4 genotype and volumetric indices was examined...
Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodiesJ A Court
Joint MRC University of Newcastle Centre Development in Clinical Brain Ageing, MRC Building, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
Pharmacol Biochem Behav 70:571-9. 2001..001). Loss of cortical alpha 7 nicotinic receptors may contribute to hallucinations and delusional misidentification in DLB, with implications for treatment and understanding the mechanisms of psychotic symptoms in dementia...
Changes in DWI and MRS associated with white matter hyperintensities in elderly subjectsM J Firbank
Wolfson Research Centre, Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
Neurology 61:950-4. 2003..To assess normal-appearing white matter (NAWM) characteristics by magnetic resonance spectroscopy (MRS) and diffusion-weighted imaging (DWI) in elderly subjects...
A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depressionA J Thomas
School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
Neuropathol Appl Neurobiol 32:296-303. 2006..In a group of subjects more typical of late-life depression we did not identify any alterations in SERT density...
Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementiaE J Burton
Institute for Ageing and Health, Newcastle University, UK
Int J Geriatr Psychiatry 27:1267-74. 2012..The purpose of this study was to investigate the neuropathological substrates underlying in vivo hippocampal atrophy on magnetic resonance imaging (MRI) in autopsy confirmed neurodegenerative dementia cases...
Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in NewcastleS Pakrasi
Institute of Ageing and Health, Wolfson Research Centre, Newcastle upon Tyne, UK
Int J Geriatr Psychiatry 18:879-86. 2003..There are few data on the patterns and predictors of response to AChEI therapy in routine clinical practice. We therefore investigated clinical variables that may distinguish between AChEI responders and non-responders...
Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumI G McKeith
Institute for Ageing and Health, University of Newcastle upon Tyne, UK
Neurology 65:1863-72. 2005....
A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's diseaseM J Firbank
Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
Dement Geriatr Cogn Disord 14:64-76. 2002..This may aid in the diagnosis of PSP. Further research is needed to determine spectroscopic changes in other dementias, to monitor how markers change with disease progression and to establish clinical utility...
Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesionsR A Kenny
MRC Institute for Ageing and Health, University of Newcastle upon Tyne, UK
J Neurol Neurosurg Psychiatry 75:966-71. 2004..Carotid sinus syndrome (CSS) is a common cause of syncope in older persons. There appears to be a high prevalence of carotid sinus hypersensitivity (CSH) in patients with dementia with Lewy bodies (DLB) but not in Alzheimer's disease...
A neuropathological study of vascular factors in late-life depressionA J Thomas
Department of Psychiatry, University of Newcastle upon Tyne, UK
J Neurol Neurosurg Psychiatry 70:83-7. 2001..Postmortem tissue was investigated to determine whether late life depression was associated with atheromatous change in large and medium vessels and microvascular disease in the brain...
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular diseaseGary Small
Department of Psychiatry and Biobehavioral Sciences and Neuropsychiatric Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90024, USA
CNS Drugs 17:905-14. 2003....
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementiaTimo Erkinjuntti
Department of Clinical Neurosciences, Helsinki University Central Hospital, Helsinki, Finland
Clin Ther 25:1765-82. 2003....
Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's diseaseSean Lilienfeld
Janssen Pharmaceutical Inc, Janssen Research Foundation, Division of Janssen Pharmaceutica Ltd, 1125 Trenton Harbourton Road, Titusville, NJ 08560, USA
CNS Drug Rev 8:159-76. 2002..Galantamine may, therefore, help to reduce the overall burden and cost involved in caring for dementia patients. Taking all evidence into account, galantamine has the potential to become a first-line therapy for dementia...
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialTimo Erkinjuntti
Department of Clinical Neurosciences, Helsinki University Central Hospital, Helsinki, Finland
Lancet 359:1283-90. 2002..We investigated the effects of galantamine in patients with a diagnosis of probable vascular dementia or Alzheimer's disease combined with cerebrovascular disease...
Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamineJeffrey S Markowitz
Health Data Analytics, Princeton Junction, NJ 08550, USA
Sleep 26:602-6. 2003..To recognize the potential effect of acetylcholinesterase-inhibiting medications on sleep quality when used for the treatment of mild to moderate Alzheimer disease and describe sleep outcomes for patients treated with galantamine...
Cholinesterase inhibitors for Alzheimer diseaseSean Lilienfeld
JAMA 289:2360; author reply 2360-1. 2003
Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamineRoger Bullock
Kingshill Research Centre, Victoria Hospital, Swindon, UK
Dement Geriatr Cogn Disord 17:29-34. 2004..The results of this subgroup analysis indicate that galantamine is effective for long-term maintenance of the cognitive function in patients with AD + CVD and is safe and well tolerated in this patient population...
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's diseaseGordon Wilcock
Department of Care of the Elderly, University of Bristol, Frenchay Hospital, Bristol, UK
Drugs Aging 20:777-89. 2003..CONCLUSIONS: Significant advantages were found in the treatment response to galantamine (versus donepezil) on cognition as measured by response rates on the MMSE and ADAS-cog/11...
